Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

Trendlines teams up with Ozi Amanat as Startup SG Equity co-investors

By: 
Michelle Zhu
08/02/18, 05:36 pm

SINGAPORE (Feb 8): Trendlines Medical Singapore, a subsidiary of Israeli company The Trendlines Group, is partnering Singapore-based investor Ozi Amanat’s venture capital firm, K2 Global, to collaborate in SPRING SEEDS Capital’s (SSC) $100 million investment allocation via the Startup SG Equity scheme.

Under the Startup SG Equity scheme, SSC supports early-stage startups across the technology and industry domain areas, and catalyses private-sector investments for startups via government equity co-investment.

The scheme announced its $100 million investment allocation in July 2017 to groom start-ups, and issued a call to its appointed partners to co-invest in the health & biomedical sciences and other fields.

In a Thursday announcement, Trendlines says it intends to invest in medical technology companies seeking Series A funding through its partnership with K2 Global. Both companies anticipate co-investing with SCC in more than 11 companies over the agreed partnership period of eight years.

They also consider the pipeline of deals originating from Trendlines Medical Singapore’s incubator, along with other companies that have strong development focus in Singapore, as “a rich environment for investment”.

Eric Loh, CEO of Trendlines Medical Singapore, sees the collaboration as one that leverages Trendlines’ experience and track record in identifying, incubating and grooming medical technology companies, while working closely with K2 Global to provide growth capital and support to help scale operations and facilitate global opportunities.

“This is an ideal relationship that will contribute substantial value to Singapore’s medical technology start-up ecosystem,” says Loh.

“Our participation in the Startup SG Equity program broadens our ability to develop early-stage medical technology companies in Singapore. Our collaboration with K2 Global will further strengthen our successful efforts in raising funds from strategic investors to boost the value of our portfolio companies. We expect numerous successful investment outcomes in the coming years,” adds Todd Dollinger, chairman of Trendlines Medical Singapore.

Shares in Trendlines close flat at 14 cents on Thursday. 

Jokowi declared winner a month after Indonesia presidential vote

(May 21): Indonesian President Joko Widodo won last month’s bitterly contested election by a double-digit margin, official results showed Tuesday, putting the former furniture exporter in charge of the world’s largest Muslim-majority nation for another five years. Widodo, known as Jokowi, won 55.5% of the national vote, compared to his challenger Prabowo Subianto’s 44.5%, the General Elections Commission said in Jakarta early on Tuesday. Jokowi’s margin of victory at 11% was almost double the lead he secured in 2014 against the same opponent, commission’s data showed. The tally al....
Read More >>

Sembcorp Industries' near-term outlook hinges on sustained India uptrend, say analysts

SINGAPORE (May 21): CGS-CIMB Research and DBS Vickers Securities are maintaining their “add” and “buy” calls on Sembcorp Industries (SCI) with target prices of $3.41 and $3.90, respectively. This comes after the group last week posted 21% higher 1Q earnings of $77 million on higher contributions from its energy segment, which was mainly driven by improved performance from India and the recognition of peak winter availability payments for UK Power Reserve. In a May 15 report, CGS-CIMB analyst Lim Siew Khee says she considers SCI cheap at $2.54, which is 0.6 times FY19 price-to-boo....
Read More >>

China warns about 'unwavering resolve' to fight 'US bullying'

BRUSSELS (May 21): China could retaliate against the US after President Donald Trump blacklisted Huawei Technologies Co., the Chinese ambassador to the European Union said. Trump upped the ante in his trade dispute with China last week, announcing moves to curb Huawei’s business that are starting to have ramifications for other companies around the world. "This is wrong behavior, so there will be a necessary response," Zhang Ming, China’s envoy to the EU, said in an interview in Brussels on Monday. "Chinese companies’ legitimate rights and interests are being undermined, so the Chi....
Read More >>